These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
8. Antisense and RNAi: powerful tools in drug target discovery and validation. Lavery KS; King TH Curr Opin Drug Discov Devel; 2003 Jul; 6(4):561-9. PubMed ID: 12951819 [TBL] [Abstract][Full Text] [Related]
9. Application of antisense oligonucleotides for gene functionalization and target validation. Bennett CF; Cowsert LM Curr Opin Mol Ther; 1999 Jun; 1(3):359-71. PubMed ID: 11713801 [TBL] [Abstract][Full Text] [Related]
10. Antisense oligonucleotides as therapeutics for malignant diseases. Ho PT; Parkinson DR Semin Oncol; 1997 Apr; 24(2):187-202. PubMed ID: 9129689 [TBL] [Abstract][Full Text] [Related]
13. [Current status of antisense drugs]. Li XJ Sheng Li Ke Xue Jin Zhan; 2000 Apr; 31(2):115-9. PubMed ID: 12545727 [TBL] [Abstract][Full Text] [Related]
14. Discovery and development of respirable antisense therapeutics for asthma. Sandrasagra A; Leonard SA; Tang L; Teng K; Li Y; Ball HA; Mannion JC; Nyce JW Antisense Nucleic Acid Drug Dev; 2002 Jun; 12(3):177-81. PubMed ID: 12162700 [TBL] [Abstract][Full Text] [Related]
15. Overview of target validation and the impact of oligonucleotides. Jones SW; Lindsay MA Curr Opin Mol Ther; 2004 Oct; 6(5):546-50. PubMed ID: 15537056 [TBL] [Abstract][Full Text] [Related]
16. AEG-35156, an antisense oligonucleotide against X-linked inhibitor of apoptosis for the potential treatment of cancer. Tamm I Curr Opin Investig Drugs; 2008 Jun; 9(6):638-46. PubMed ID: 18516763 [TBL] [Abstract][Full Text] [Related]
17. [Antisense oligonucleotides--a new generation of potential drugs]. Moser HE Praxis (Bern 1994); 1995 Sep; 84(38):1055-6. PubMed ID: 7481305 [No Abstract] [Full Text] [Related]
18. PRO-051, an antisense oligonucleotide for the potential treatment of Duchenne muscular dystrophy. Hammond SM; Wood MJ Curr Opin Mol Ther; 2010 Aug; 12(4):478-86. PubMed ID: 20677099 [TBL] [Abstract][Full Text] [Related]
19. Oligonucleotide technologies: synthesis, production, regulations and applications. 29-30th November 2000, Hamburg, Germany. Uhlmann E Expert Opin Biol Ther; 2001 Mar; 1(2):319-28. PubMed ID: 11727539 [TBL] [Abstract][Full Text] [Related]